Clinical trials recruiting for Systemic Scleroderma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CD19 targeted CAR-T cells | 1 |
| Cabozantinib | 1 |
| Fluoropyrimidine | 1 |
| Ipilimumab | 1 |
| Nivolumab | 1 |
| Platinum Compound | 1 |
| Platinum Doublet | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| California | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Related conditions
Trials recruiting for Systemic Scleroderma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Systemic Scleroderma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.